-
5m 20sPart 1 | Session 19 Patient Selection in NIVL and Preventing Migration in Venous Stenting
-
4m 28sPart 1 | Session 1 GPX Embolic Device In Peripheral Applications
-
5m 32sPart 1 | Session 2 B-CLEAR Registry: Timing of TEVAR in Type B Aortic Dissection
-
4m 16s
-
3m 58sPart 1 | Session 4 Cre8™ BTK Clinical Results in Complex BTK Patients
-
4m 25sPart 1 | Session 5 AVF Formation with Adjuvant Endovascular Maturation
-
6m 16sPart 1 | Session 6 Long-Term Results of Supera in AVF Junta-Anastomosis
-
6m 42sPart 1 | Session 7 SirPAD RCT: Sirolimus-Coated DCBs in Pts with PAD
-
2m 39sPart 1 | Session 8 PRELUDE-BTK With Dr Lichtenberg: Serranator® PTA in Pts With PAD
-
4m 46sPart 1 | Session 9 PRIZER Study: Renzan™ Stent in Pts With PAD
-
5m 16sPart 1 | Session 10 Auryon-SCE: Real-World Cohort Shows Promising Freedom from TLR at 6M
-
5m 32sPart 1 | Session 11 JET-RANGER: Jetstream Atherectomy & DCB In Pts With Complex Calcified Lesions
-
5m 43sPart 1 | Session 12 FLEX RCT: Micro-Incision prior to PTA in Pts With AVF
-
2m 46sPart 1 | Session 13 BioMimics 3D Stent: Safety and Efficacy in Real-World Patients
-
2m 44sPart 1 | Session 14 P-MAX Study with Dr Lichtenberg: ASPIREX®S Endovascular System
-
2m 15sPart 1 | Session 15 Cost-Effectiveness of Urea Excipient-Based DCBs for CLTI
-
7m 57sPart 1 | Session 16 The CLariTI Study: Natural Progression of CLTI
-
4m 19sPart 1 | Session 17 PAD in Germany 2009-2018 With Dr Rammos
Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Expert Interviews
Faculty Biographies
Marianne Brodmann
Professor, Head of the Clinical Division of Angiology
Dr Marianne Brodmann is the Head of Division of Angiology, Head of Clinical Research at Division of Angiology at the Medical University of Graz, Austria.
Dr Brodmann is a Fellow of the European Society of Cardiology, Board Member of the European Union of Medical Specialist (UEMS), past President of the ÖGA (Austrian Society of Angiology) and National Delegate of the IUA (International Union of Angiology).
Research activities include anticoagulation and thrombolysis, new endovascular technologies in the peripheral field and evaluation of the nature of restenosis. She also founded a research establishment for experimental angiology animal models at the University of Graz.
Dr Brodmann has participated in over 50 international clinical trials including Principal Investigator for the Bioflex I, Lutonix BTK and TOBA-BTK clinical trials and Steering Committee of the CVI Ingenuity trial.